Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Regulation and signaling pathways in cancer stem cells: implications for targeted therapy for cancer
Zhen Zeng, Minyang Fu, Yuan Hu, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Ratiometric Near-Infrared Fluorescent Probe Monitors Ferroptosis in HCC Cells by Imaging HClO in Mitochondria
Bo Zhao, Xionghao Xu, Xin Wen, et al.
Analytical Chemistry (2024) Vol. 96, Iss. 15, pp. 5992-6000
Closed Access | Times Cited: 25
Kinase Inhibitors and Kinase-Targeted Cancer Therapies: Recent Advances and Future Perspectives
Jiahao Li, Gong Chen, Haiting Zhou, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5489-5489
Open Access | Times Cited: 20
lncRNA-microRNA axis in cancer drug resistance: particular focus on signaling pathways
Raed Obaid Saleh, Mushtak T.S. Al-Ouqaili, Eyhab Ali, et al.
Medical Oncology (2024) Vol. 41, Iss. 2
Closed Access | Times Cited: 18
Hallmarks of cancer resistance
Muhammad Tufail, Jia-Ju Hu, Jie Liang, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109979-109979
Open Access | Times Cited: 18
ALDH and cancer stem cells: Pathways, challenges, and future directions in targeted therapy
Kousalya Lavudi, Shreya Madhav Nuguri, Prashant Pandey, et al.
Life Sciences (2024) Vol. 356, pp. 123033-123033
Closed Access | Times Cited: 14
Effective therapy of advanced breast cancer through synergistic anticancer by paclitaxel and P-glycoprotein inhibitor
Sifeng Zhu, Chao Sun, Zimin Cai, et al.
Materials Today Bio (2024) Vol. 26, pp. 101029-101029
Open Access | Times Cited: 6
Cancer Stem Cells from Definition to Detection and Targeted Drugs
Barbara Ruszkowska-Ciastek, Katarzyna Kwiatkowska, Dorinda Marques‐da‐Silva, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3903-3903
Open Access | Times Cited: 5
The Role of TAMs in the Regulation of Tumor Cell Resistance to Chemotherapy
Ryan McWhorter, Benjamin Bonavida
Critical Reviews™ in Oncogenesis (2024) Vol. 29, Iss. 4, pp. 97-125
Closed Access | Times Cited: 5
Design of a theranostic Gd (III)–Cu (I) complex to inhibit growth and metastasis of triple-negative breast cancer
Xueyu Man, Minghui Zhu, Shanhe Li, et al.
Rare Metals (2025)
Closed Access
Molecular Mechanisms of Dietary Compounds in Cancer Stem Cells from Solid Tumors: Insights into Colorectal, Breast, and Prostate Cancer
Alexandru Filippi, Teodora Deculescu-Ioniță, Ariana Hudiță, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 631-631
Open Access
Drug resistance in TKI therapy for hepatocellular carcinoma: mechanisms and strategies
Xue Jiang, Xiaoying Ge, Yueying Huang, et al.
Cancer Letters (2025), pp. 217472-217472
Closed Access
Beyond Chemotherapy: Exploring 5-FU Resistance and Stemness in Colorectal Cancer
Urmila Singh, Rekha Rani Kokkanti, Srinivas Patnaik
European Journal of Pharmacology (2025), pp. 177294-177294
Closed Access
Radioresistance in rectal cancer: can nanoparticles turn the tide?
Diogo Luiz Coelho, Diogo Estêvão, Maria José Oliveira, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
An update on cancer stem cell survival pathways involved in chemoresistance in triple-negative breast cancer
Asma Jan, Shazia Sofi, Nusrat Jan, et al.
Future Oncology (2025), pp. 1-21
Closed Access
Rational Design of a Potent, Selective, and Metabolically Stable CDK9 Inhibitor to Counteract Osimertinib Resistance through Mcl-1 Suppression and Enhanced BRD4 Co-Targeting
Ti-Zhi Wu, Jiali Huang, Xiankang Zhang, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Impact of G1 phase kinetics on the acquisition of stemness in cancer cells: the critical role of cyclin D
Yasin Ahmadi, Tahran Faiq, Sakhavat Abolhasani
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access
Selected Elements of the Tumor Microenvironment (MMP-2, MMP-7, TIMP-2, CXCL-9, CXCL-10) in the Serum of Pediatric Patients with Acute Lymphoblastic Leukemia
Aleksandra Kaczorowska, Natalia Miękus, Anna Owczarzak, et al.
Cells (2025) Vol. 14, Iss. 4, pp. 297-297
Open Access
Exploring the potential of stem cell therapy: Applications, types, and future directions
KeerthiShri Boopathy, Thirunavukkarasu Palaniyandi, Maddaly Ravi, et al.
Acta Histochemica (2025) Vol. 127, Iss. 2, pp. 152237-152237
Closed Access
CD146 regulates the stemness and chemoresistance of hepatocellular carcinoma via JAG2-NOTCH signaling
Bing Yan, Qiang Lü, Tianming Gao, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Targeting stemness pathways modulates macrophage polarization and reprograms the tumor microenvironment
Austeja Butkute, Marius Baltramonaitis, Simona Malmige, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Unveiling the future of cancer stem cell therapy: a narrative exploration of emerging innovations
Joseph Nhyira Obisi, Abike Ndidiamaka Josephine Abimbola, Oluwasegun Adesina Babaleye, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
Role of noncoding RNA as a pacemaker in cancer stem cell regulation: a review article
Yasmin M. Attia, Samer A. Tadros, Sally A. Fahim, et al.
Journal of the Egyptian National Cancer Institute (2025) Vol. 37, Iss. 1
Open Access
Alcohol-Metabolizing Enzymes, Liver Diseases and Cancer
Tao Liu, Feiyu Zhang, Yue Feng, et al.
Seminars in Liver Disease (2025)
Open Access
The Function of Circular RNAs in Regulating Wnt/β-Catenin Signaling: An Innovative Therapeutic Strategy for breast and gynecological Cancers
Samaneh Kahkesh, Neda Hedayati, Payman Rahimzadeh, et al.
Pathology - Research and Practice (2025), pp. 155944-155944
Closed Access
Traditional Chinese medicine and natural products in management of hepatocellular carcinoma: Biological mechanisms and therapeutic potential
Yuqiang Xun, Guang Chen, Guping Tang, et al.
Pharmacological Research (2025), pp. 107733-107733
Open Access
Page 1 - Next Page

Scroll to top